98%
921
2 minutes
20
Background: Basosquamous carcinoma (BSC) is a rare and aggressive nonmelanoma skin cancer (NMSC) that exhibits features of both BCC and squamous cell carcinoma (SCC). The gold standard for diagnosis is histopathological examination. BSC is often challenging to diagnose and manage due to its mixed histological features and potential for aggressive behavior AIM: To identify specific features aiding clinicians in differentiating BSCs using non-invasive diagnostic techniques.
Methods: We conducted a retrospective descriptive, monocentric study of the epidemiological clinical, dermoscopic, and reflectance confocal microscopy (RCM) features of histopathologically proven BSCs diagnosed between 2010 and 2023. A total of 192 cases were selected.
Results: The study population consisted of 17 men (60.9%). Total 95.8% of patients at the time of diagnosis were ≥50 years. BSC occurred in the head and neck area in 124 cases (63.1%) of which 65 (33.9%) were in the H-zone. For 47.4% of patients, BSC presented as a macule with undefined clinical margins (43.3%). Dermoscopic images were available for 98 cases: the most common parameter was the presence of whitish structureless areas (59 [60.2%]), keratin masses (58 [59.2%]), superficial scales, and ulceration or blood crusts (49 [50%] both). Vessels pattern analysis revealed hairpin vessels (exclusively) and linear irregular vessels as the most frequent (55 [56.1%] both). RCM examination was performed in 21 cases which revealed specific SCC features such as solar elastosis (19 [90.5%]), atypical honeycomb pattern (17 [89%]), proliferation of atypical keratinocytes (16 [80%]) combined with BCC' ones as bright tumor islands (12 [57.8%]), and cleft-like dark spaces (11 [53.4%]).
Discussion: Our study reflects the largest cohort of BSCs from a single institution. We described an incidence rate of 4.7%, higher than reported in the Literature, with the involvement of patients ≥50years in almost 96% of cases and an overall male predominance. At clinical examination, BSC was described as a hyperkeratotic macule with undefined clinical margins with one or more dermoscopic SCC' features, whereas the presence of typical BCC aspects was observed in less than 10% of cases, differently from what was previously reported. At RCM analysis, BSCs presented with an atypical honeycomb pattern with proliferation of atypical keratinocytes, hyperkeratosis, and in nearly 55% of patients, bright tumor islands with cleft-like dark spaces.
Conclusion: The distinctive dermoscopic patterns, along with the RCM features aid in the differentiation of BSCs from other NMSCs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11321334 | PMC |
http://dx.doi.org/10.1111/srt.70012 | DOI Listing |
Cancer Rep (Hoboken)
September 2025
Dermatology Department, Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Background: Non-melanoma skin cancers (NMSC) are the most frequent cutaneous tumors globally. Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) represent the most frequently encountered representatives of this group and may represent a diagnosis challenge in some circumstances of hard to differentiate tumors.
Aims: The aim of this study was to determine the factors that influence the diagnosis of NMSC and their impact.
Clin Exp Med
August 2025
Pathology Division, National Institute for Occupational Health, National Health Laboratory Service, Johannesburg, South Africa.
Basal cell carcinoma is a non-melanoma skin cancer arising from basal epidermal keratinocytes. Its incidence is on the rise in the African continent and has been reported as the common skin malignancy worldwide, with a male predominance. The BCC subtypes are divided into low- and high-risk types based on prognostic characteristics.
View Article and Find Full Text PDFSkin Health Dis
June 2025
Department of Pathology, University of Rochester Medical Center, Rochester, NY, USA.
Basal cell carcinoma (BCC), the most common skin cancer worldwide, is closely associated with sunlight exposure and generally exhibits a low metastatic potential, with a frequency ranging from 0.0028% to 0.55%.
View Article and Find Full Text PDFAustralas J Dermatol
June 2025
Skin Health Institute, Carlton, Victoria, Australia.
This retrospective analysis of Hedgehog inhibitor treatment in 32 patients with Gorlin syndrome, locally advanced and metastatic basal cell carcinoma (BCC) at three tertiary referral centres in Victoria, Australia from April 2017 until 30 June 2024 demonstrated an 84% overall objective response rate (partial and complete response combined). However, 90% of patients experienced adverse effects impacting quality of life. Secondary acquired drug resistance occurred in 77% (10/13) of locally advanced and metastatic BCC patients after a median duration of 13 months.
View Article and Find Full Text PDFPhotodiagnosis Photodyn Ther
August 2025
Dermatology Hospital of Southern Medical University, Guangzhou, Guangdong, China. Electronic address:
Background: Locally advanced basal cell carcinoma (laBCC) is a more severe subtype of BCC, characterized by large, deeply invasive tumors that often occur in cosmetically or functionally sensitive areas. Mohs micrographic surgery (MMS) is the standard treatment, offering high cure rates through layer-by-layer excision with microscopic margin control. However, MMS alone may not entirely prevent recurrence in aggressive or infiltrative subtypes.
View Article and Find Full Text PDF